Canadian Ophthalmological Society policy statement on the medical use of marijuana for glaucoma;Énoncé de principe de la Société canadienne d'ophtalmologie sur l'utilisation médicale de la marijuana pour le glaucome

Canadian Journal of Ophthalmology

Volumn 45, Issue 4, 2010, Pages 324-326

  Buys, Yvonne M ^a   Rafuse, Paul E ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; DRONABINOL;

ALTERNATIVE MEDICINE; CANADA; CANNABIS ADDICTION; COGNITIVE DEFECT; COORDINATION; CORNEA INJURY; DRUG ABSORPTION; DRUG PENETRATION; DRUG TOLERANCE; DYSPHORIA; EDITORIAL; EMPHYSEMA; EUPHORIA; EYE IRRITATION; GLAUCOMA; HEART PALPITATION; HUMAN; HYPOTENSION; INTRAOCULAR PRESSURE; LUNG CANCER; MEDICAL SOCIETY; OPHTHALMOLOGY; POLICY; SHORT TERM MEMORY; SIDE EFFECT; SOMNOLENCE; TACHYCARDIA; CANNABIS SMOKING; DRUG EFFECTS; HEALTH CARE POLICY; STANDARDS;

CANADA; COMPLEMENTARY THERAPIES; DRONABINOL; GLAUCOMA; HEALTH POLICY; HUMANS; INTRAOCULAR PRESSURE; MARIJUANA SMOKING; OPHTHALMOLOGY; SOCIETIES, MEDICAL;

EID: 77955464556     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.3129/i10-069     Document Type: Editorial

References (23)

1. National Center for Complementary and Alternative Medicine. What is Complementary and Alternative Medicine? Available at: http://nccam.nih.gov/ health/whatiscam/. AccessedMarch 10, 2009.
2. Tindle HA, Davis RB, Phillips RS, Eisenberg DM. Trends in use of complementary and alternative medicine by US adults: 1997-2002. Altern Ther Health Med 2005;11:42-9.
3. Ni H, Simile C, Hardy AM. Utilization of complementary and alternative medicine by United States adults: results from the 1999 national health interview survey. Med Care 2002;40:353-8.
4. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998;280:1569-75.
5. Kogan NM, Mechoulam R. Cannabinoids in health and disease. Dialogues Clin Neurosci 2007;9:413-30.
6. Hepler RS, Frank IR. Marihuana smoking and intraocular pressure. JAMA 1971;217:1392.
7. Form B2. Medical practitioner's form for category 2 applicants. Available at: http://www.hc-sc.gc.ca/dhp-mps/alt-formats/hecs-sesc/pdf/marihuana/how- comment/applicantdemandeur/form-b2-eng.pdf. Accessed April 26, 2010.
8. Canadian Ophthalmological Society policy statement on the medical use of marijuana forfor glaucoma. Available at: http:// www.eyesite.ca/english/program- and-services/policy-statementsguidelines/MedicalUseofMarijuanaforGlaucoma-2010- en.pdf. Accessed April 26, 2010.
9. Zias J, Stark H Sellgman J, et al. Early medical use of cannabis. Nature 1993;363:215.
10. Gaoni Y, Mechoulam R. Isolation, structure and partial synthesis of the active constituent of hashish. J Am Chem Soc 1964;86:1646-7.
11. Merritt JC, Crawford WJ, Alexander PC, Anduze AL, Gelbart SS. Effect of marihuana on intraocular and blood pressure in glaucoma. Ophthalmology 1980;87:222-8.
12. Merritt JC, McKinnon S, Armstrong JR, Hatem G, Reid LA. Oral delta 9-tetrahydrocannabinol in heterogeneous glaucomas. Ann Ophthalmol 1980;12:947-50.
13. Purnell WD, Gregg JM. Delta(9)-tetrahydrocannabinol, euphoria and intraocular pressure in man. Ann Ophthalmol 1975;7:921-3.
14. Tomida I, Azuara-Blanco A, House H, Fling M, Pertwee RG, Robson PJ. Effect of sublingual application of cannabinoids on intraocular pressure: a pilot study. J Glaucoma 2006;15:349-53.
15. Merritt JC, Olsen JL, Armstrong JR, McKinnon SM. Topical delta 9-tetrahydrocannabinol in hypertensive glaucomas. J Pharm Pharmacol 1981;33:40-1.
16. Green K, Roth M. Ocular effects of topical administration of delta 9-tetrahydrocannabinol in man. Arch Ophthalmol 1982; 100:265-7.
17. Jay WM, Green K. Multiple-drop study of topically applied 1% delta 9-tetrahydrocannabinol in human eyes. Arch Ophthalmol 1983;101:591-3.
18. Green K, Podos SM. Antagonism of arachidonic acid-induced ocular effects by D1-tetrahydrocannabinol. Invest Ophthalmol 1974;13:422-9.
19. Porcella A, Casellas P, Gessa GL, Pani L. Cannabinoid receptor CB1 mRNA is highly expressed in the rat ciliary body: implications for the antiglaucoma properties of marihuana. Brain Res Mol Brain Res 1998;58:240-5.
20. Zhan GL, Camras CB, Palmber PF, Toris CB. Effects of marijuana on aqueous humor dynamics in a glaucoma patient. J Glaucoma 2005;14:175-7.
21. Brown B, Adams AJ, Haegerstrom-Portnoy G, Jones RT, Flom MC. Pupil size after use of marijuana and alcohol. Am J Ophthalmol 1977;83:350-4.
22. Hashibe M, Ford DE, Zhang ZF. Marijuana smoking and head and neck cancer. J Clin Pharmacol 2002;42(Suppl):103S-7S.
23. Flom MC, Adams AJ, Jones RT. Marijuana smoking and reduced pressure in human eyes: drug action or epiphenomenon? Invest Ophthalmol 1975;14:52-5.